News

In the United States, liver transplants and overall liver-related mortality outcomes highlight significant differences in ...
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is set to showcase critical new findings on resmetirom, its ...
The ability to predict well in advance could allow for early intervention and prevention. Researchers have discovered five ...
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.
Researchers have found in a new cohort study that the use of statins in patients with chronic liver disease was associated ...
Five plasma proteins may predict a patient’s risk for metabolic dysfunction-associated steatotic liver disease up to 16 years ...
White patients had an increased burden of advanced liver fibrosis vs Black patients, despite comparable levels of inflammation.
Mar. 24, 2025 — A comprehensive study shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both ...
The risk of death was higher in certain children, especially boys and those with low levels of high-density lipoprotein (HDL) ...
HealthDay News — Five proteins are significant predictors of metabolic dysfunction-associated steatotic liver disease (MASLD), according to a study presented at the 2025 Digestive Disease Week, held ...
The doctors also cautioned against self-medication and unregulated herbal remedies, advocating lifestyle modifications and ...